Evidence map›Paper›PMID 35766615›Full record

ArticleArquivos brasileiros de cardiologia2022

Systemic Immune-Inflammatory Index as a Determinant of Atherosclerotic Burden and High-Risk Patients with Acute Coronary Syndromes.

Demet Ozkaramanli Gur, Muhammet Mucip Efe, Seref Alpsoy, Aydın Akyüz, Nurullah Uslu, Aliye Çelikkol, Ozcan Gur

Open access · diamondAbstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Influence of the Immune System on Cardiovascular Disease.Arquivos brasileiros de cardiologia · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Demet Ozkaramanli GurNamik Kemal University,Faculty of Medicine, Department of Cardiology, Tekirdag - Turquia.ORCID 0000-0003-2542-8196
Muhammet Mucip EfeNamik Kemal University,Faculty of Medicine, Department of Cardiology, Tekirdag - Turquia.ORCID 0000-0001-9153-0995
Seref AlpsoyNamik Kemal University,Faculty of Medicine, Department of Cardiology, Tekirdag - Turquia.ORCID 0000-0003-3720-0076
Aydın AkyüzNamik Kemal University,Faculty of Medicine, Department of Cardiology, Tekirdag - Turquia.ORCID 0000-0003-3304-4125
Nurullah UsluNamik Kemal University,Faculty of Medicine, Department of Cardiology, Tekirdag - Turquia.ORCID 0000-0002-3152-8292
Aliye ÇelikkolNamik Kemal University,Faculty of Medicine, Biochemistry Department, Tekirdag - Turquia.ORCID 0000-0002-3799-4470
Ozcan GurNamik Kemal University,Faculty of Medicine, Department of Cardiovascular Surgery, Tekirdag - Turquia.ORCID 0000-0001-9321-1699
Tekirdağ Namık Kemal University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic immune-inflammatory index (SII), which is derived from neutrophil, platelet and lymphocyte counts, represents the homeostatic balance among inflammatory, immune and thrombotic status. The systemic immune-inflammatory index is superior to indices such as neutrophil-lymphocyte ratio in predicting prognosis in various malignancies, while it is shown to predict future cardiac events better than traditional risk factors after coronary intervention.

objectivesHerein, we aimed to evaluate the relationship of the systemic immune-inflammatory index with atherosclerotic burden and in-hospital complications in acute coronary syndrome patients.

methodsThe clinical outcomes, such as extent of myocardial damage, atherosclerotic burden, bleeding, acute kidney injury, duration of hospital stay and in-hospital mortality, were evaluated in a retrospective cohort of 309 consecutive acute coronary syndrome patients. The systemic immune-inflammatory index was calculated as (Platelet X Neutrophil)/Lymphocyte count on admission. Study population was categorized into tertiles with regard to systemic immune-inflammatory index. A p value of <0.05 was considered statistically significant.

resultsThe highest systemic immune-inflammatory index values were within ST elevation myocardial infarction patients (641.4 in unstable angina pectoris, 843.0 in non-ST elevation myocardial infarction patients and 996.0 in ST elevation myocardial infarction patients; p=0.004). Maximal troponin concentration (0.94 vs. 1.26 vs. 3; p<0.001), number of diseased vessels (1 vs. 2 vs. 2; p<0.001), the SYNTAX (synergy between percutaneous coronary intervention with taxus and coronary artery bypass grafting) score (9 vs. 14 vs. 17.5; p<0.001) and duration of hospital stay (2 vs. 2 vs. 3; p<0.001) also increased with increasing SIItertile(tertile1 vs. tertile 2 vs. tertile 3). Systemic immune-inflammatory index was an independent predictor of SYNTAX score (ß: 0.232 [0.001 to 0.003]; p<0.001), extent of myocardial damage (ß: 0.152 [0 to 0.001]; p=0.005) and duration of hospital stay (ß: 0.168 [0.0 to 0.001]; p=0.003).

conclusionsThis study has demonstrated that the systemic immune-inflammatory index, a simple hematological index, is a marker of atherosclerotic burden and longer hospital stay on well-known risk factors in high risk acute coronary syndrome patients.

Indexed as

Acute Coronary SyndromePercutaneous Coronary InterventionST Elevation Myocardial InfarctionCoronary AngiographyHumansPredictive Value of TestsPrognosisRetrospective StudiesRisk AssessmentRisk Factors

Identifiers

PMID35766615
PMCPMC9438541
OpenAlexW4283464434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.